Michael S. Labson earned his J.D. from Harvard Law School in 1994. His practice spans the full range of pharmaceutical and medical device regulation. He provides strategic advice in dealing with the FDA and other agencies. Mr. Labson’s recent work has involved issues such as: clinical trial conduct, FDA dispute resolution, user fees, orphan drugs, pediatric and market exclusivities, product promotion, anti-kickback compliance, Medicaid rebates, drug samples, GMP and quality system requirements, FOIA, imports and exports, drug pedigrees, life cycle planning, and pharmaco-vigilance.
Mr. Labson is actively involved in pro bono work, focusing on civil rights and capital representations. He is one of the firm's two Hiring Partners in Washington, and previously was Co-Chair of the firm’s Diversity Committee.